Restless Legs Syndrome (RLS) is a common yet
|
|
- Arleen Butler
- 6 years ago
- Views:
Transcription
1 Restless Legs Syndrome is Associated with DSM-IV Major Depressive Disorder and Panic Disorder in the Community Hochang B. Lee, M.D. Wayne A. Hening, M.D, Ph.D. Richard P. Allen, Ph.D. Amanda E. Kalaydjian, Ph.D. Christopher J. Earley, M.B.B.Ch., Ph.D. William W. Eaton, Ph.D. Constantine G. Lyketsos, M.D., M.H.S. The authors examined the association between restless legs syndrome (RLS) and DSM-IV major depressive disorder and panic disorder based on Wave III and IV of the Baltimore ECA follow-up study. Of 1071 participants, 1024 completed the RLS Questionnaire and Diagnostic Interview Schedule. Adjusted odds ratio for diagnosis of major depressive disorder (4.7, 95% confidence interval [1.6, 14.5]) and panic disorder (12.9 [3.6, 46.0]) and comorbidity of major depressive disorder and panic disorder (9.7 [1.4, 69.0]) in the past 12 months suggested a strong association between restless legs syndrome and major depressive disorder and/or panic disorder. (The Journal of Neuropsychiatry and Clinical Neurosciences 2008; 20: ) Restless Legs Syndrome (RLS) is a common yet underrecognized neurological, sensorimotor disorder that affects 5% to 10% of the general adult population. 1 Several population- and clinic-based studies have reported higher depression and anxiety ratings in individuals with restless legs syndrome than without. 2 Due to reliance on mood and anxiety rating scales with questionable validity, however, clinical significance of the previous reports has remained disputable. Recently, the Baltimore Epidemiologic Catchment Area (ECA) 23-year follow-up study assessed 1071 participants for restless legs syndrome symptoms by a seven-item questionnaire and assigned psychiatric diagnoses according to responses on the Diagnostic Interview Schedule (DIS). 3 We examined the cross-sectional association between restless legs syndrome and DSM- IV major depressive disorder and panic disorder in this cohort. METHOD Sample The Epidemiologic Catchment Area program, supported by the National Institute of Mental Health (NIMH), is a community-based study of the prevalence of psychiatric disorders and is described elsewhere in detail. 4 At the Baltimore site, the original sample consisted of 3481 residents selected by probability sampling methods from three catchment areas in East Baltimore in A total of 1920 out of 3481 original participants were reinterviewed during Wave III in The study sample consists of 1071 participants (75% of the surviving participants of Wave III) who continued to participate in Wave IV in Diagnosis of RLS The symptoms of restless legs syndrome were assessed during Wave IV on a seven-item RLS Questionnaire, which was adapted and expanded from the previously validated, three-item restless legs syndrome screening questionnaire from the Memory and Morbidity in Augsburg Elderly (MEMO) Study. 5 A Received October 13, 2006; revised January 22 and February 27, 2007; accepted March 5, Drs. Lee and Lyketsos are affiliated with the Division of Geriatric Psychiatry and Neuropsychiatry, Department of Psychiatry and Behavioral Sciences at the Johns Hopkins University School of Medicine in Baltimore, Maryland; Dr. Hening is affiliated with the Department of Neurology at the University of Medicine and Dentistry of New Jersey/RW Johnson Medical School in New Brunswick, New Jersey; Drs. Allen and Earley are affiliated with the Department of Neurology at Johns Hopkins University School of Medicine in Baltimore, Maryland; Drs. Kalaydjian and Eaton are affiliated with the Department of Mental Health at the Bloomberg School of Public Health, Johns Hopkins University in Baltimore, Maryland. Address correspondence to Hochang Benjamin Lee, M.D., Assistant Professor of Psychiatry and Behavioral Sciences, The Johns Hopkins University School of Medicine, Osler 320, 600 N. Wolfe St., Baltimore, MD 21287; Hochang@jhmi.edu ( ). Copyright 2008 American Psychiatric Publishing, Inc. J Neuropsychiatry Clin Neurosci 20:1, Winter
2 RLS ASSOCIATED WITH MAJOR DEPRESSIVE AND PANIC DISORDERS comparison of restless legs syndrome case classification based on the Memory and Morbidity in Augsburg Elderly Study questionnaire, and the one based on clinical examination in the Memory and Morbidity in Augsburg Elderly Study, had a kappa of To improve the specificity of the questionnaire, we adopted a stricter, syndromal approach and required the endorsed restless legs syndrome symptoms to occur concurrently in order to reduce the number of false positives. Those who answered Yes to the following six questions were deemed to fulfill the four diagnostic criteria for restless legs syndrome as established by the International RLS Study Group 1 : 1) Do you ever feel like you just have to move your legs? 2) Do you ever have unpleasant creepy/crawly feelings in your legs? 3) Do these creepy/ crawly feelings in your legs and feelings like you have to move ever occur together, that is, at the same time? 4) Do these feelings occur mainly when you are resting? 5) Do these feelings improve with movement? 6) Are these feelings worse in the evening or night than in the morning? The questionnaire contained an additional item on the frequency of symptoms that did not contribute to restless legs syndrome case ascertainment. Assessment of Psychiatric Disorders The Diagnostic Interview Schedule is a structured interview designed for use by trained lay interviewers to make diagnoses of major mental disorders according to DSM-IV, rather than measuring general psychological distress. Reliability and validity of the Diagnostic Interview Schedule has been examined previously. 3 Based on their Wave III and IV interviews, participants were assigned a diagnosis of past-year and lifetime (ever met criteria) major depressive disorder, panic disorder, generalized anxiety disorder, and obsessive compulsive disorder. All diagnostic variables were binary (e.g., 0 no MDD, 1 MDD). Sociodemographic variables investigated were: 1) age (continuous in years); 2) ethnicity (dichotomous: white 1, nonwhite 0); 3) gender (dichotomous: female 1, male 0); 4) education (continuous in years of school). Health-related variables of interest used in these analyses included: 1) self-rating of general health (ordinal: Excellent, Good, Fair, or Poor); 2) self-report of heart disease, defined as reporting history of rheumatic heart disease, angina pectoris, heart attack, congestive heart failure, coronary angioplasty, or coronary artery bypass graft surgery; 3) history of diabetes, defined as reporting history of high sugar or diabetes; 4) current use of selective serotonin reuptake inhibitor (SSRI) or tricyclic antidepressant (TCA). Analysis We conducted a case-control analysis comparing restless leg syndrome cases with non- restless leg syndrome controls to estimate restless legs syndrome risk by sociodemographic and health-related variables. Crude odds ratios (ORs) with 95% confidence limits were calculated based on logistic regression. Adjusted odds and 95% confidence intervals were calculated based on logistic regression models with DSM-IV psychiatric diagnoses as the main outcome variables and diagnosis of restless legs syndrome as the main predictor, while adjusting for other relevant sociodemographic and health-related variables. RESULTS Table 1 displays the sociodemographic and health-related data of the sample. Of 1071 participants in Wave IV of the Baltimore Epidemiologic Catchment Area follow-up study, 1024 (women: 74%, mean age 56 years 10) responded to both the Diagnostic Interview Schedule and the seven-item RLS Questionnaire and composed the study sample. The prevalence of restless leg syndrome symptoms in the total sample was 4.2% (N 42). Of the 42 participants with restless legs syndrome symptoms, 18 (1.9%) reported that the restless legs syndrome symptoms occurred two or more times a week, indicating a restless legs syndrome severity of possible clinical significance. Among the sociodemographic and health variables, female gender, and lower self-health rating ( fair or poor ) were associated with restless legs syndrome symptoms. Table 2 summarizes the results of logistic regression models with DSM-IV psychiatric diagnoses as the main outcome variables and diagnosis of restless legs syndrome as the main predictor while adjusting for age, gender, health rating, and antidepressant use. Lifetime prevalence of any psychiatric disorders was 36.8% (n 14) among participants with restless legs syndrome and was substantially higher than in participants without restless legs syndrome (14.6%, n 129). Among the psychiatric diagnoses, DSM-IV major depressive disorder was the most common diagnosis with a lifetime and 12-month prevalence of 19.0% (n 8) and 9.5% (n 4) among participants with restless legs syndrome. Crude J Neuropsychiatry Clin Neurosci 20:1, Winter 2008
3 LEE et al. and adjusted odds ratios for a lifetime diagnosis of major depressive disorder among subjects with versus without restless legs syndrome were 2.6 (95% confidence interval [1.2, 5.5]) and 2.7 (1.1, 6.7), respectively. Crude (4.7 [1.6, 14.5]) and adjusted (4.7 [1.2, 18.3]) odds ratios for diagnosis of major depressive disorder among subjects with versus without restless legs syndrome during the past 12 months were even higher. The lifetime prevalence of panic disorder was also higher among participants with restless legs syndrome than without (16.7% versus 4.1%). Crude (4.7 [2.0, 11.1]) and adjusted (5.3 [2.0, 14.0]) odds ratios for a lifetime diagnosis of panic disorder and crude (9.5 [3.2, 27.8]) and adjusted (12.9 [3.6, 46.0]) odds ratios for a 12-month diagnosis of panic disorder among participants with versus without restless legs syndrome suggested a strong association between restless legs syndrome and panic disorder. Crude (7.9 [1.5, 40.6]) and adjusted (9.7 [1.4, 69.0]) odds ratios for having comorbidity of panic disorder and major depressive disorder in the past 12 months were elevated as well. The case sample size for other diagnoses, such as generalized anxiety disorder and OCD, was too small for comparison. The potential role of antidepressant use TABLE 1. Sociodemographic and Health-Related Variables RLS (N 42) Controls (N 982) Total (N 1042) Mean SD Mean SD p-value* Mean SD Age (yrs) Education (yrs) N % N % p-value* N % Female gender Race African-American White Others Self-health rating Excellent Good Fair Poor Heart disease Diabetes On SSRI or TCA * Results from a t-test for continuous variables and chi-square for categorical variables TABLE 2. Prevalence and Crude and Adjusted Odds Ratios for DSM-IV Psychiatric Disorders RLS (N 42) No RLS (N 982) RLS vs. Controls RLS vs. Controls N % N % Crude OR 95% CI p-value Adj. OR* 95% CI p-value MDD Lifetime , , month , , Panic disorder Lifetime , , month , , Panic disorder and MDD Lifetime , , month , , GAD , , OCD , , Any diagnosis Lifetime , , month , , * Adjusted for age, gender, health rating, and anti-depressant (SSRIs or TCAs) use. J Neuropsychiatry Clin Neurosci 20:1, Winter
4 RLS ASSOCIATED WITH MAJOR DEPRESSIVE AND PANIC DISORDERS selective serotonin reuptake inhibitors (SSRIs) or tricyclic antidepressants (TCAs) was further examined as an independent predictor for diagnosis of restless legs syndrome, but crude (0.8 [0.3, 2.0]) and adjusted (0.5 [0.2, 1.2]) odds were statistically insignificant. DISCUSSION This study is the first to report a strong association between restless legs syndrome symptoms and DSM-IV major depressive disorder and panic disorder in the community. Previously, Winkelmann et al. 6 reported high rates of major depressive disorder and panic disorder among restless legs syndrome patients in the movement disorder clinic based on a structured psychiatric interview, but inherent referral bias and lack of appropriate comparison group limited the generalizabilty of this finding. This study provides more definitive data on the association between restless legs syndrome, major depressive disorder, and panic disorder by direct comparison of the prevalence among those with and without restless legs syndrome in the same community. Several explanations are offered for the co-occurrence of restless legs syndrome and DSM-IV major depressive disorder. Up to four of the nine symptoms insomnia, loss of energy, diminished concentration, and psychomotor retardation listed in the DSM-IV diagnostic criteria for major depressive disorder can be attributed to sleep impairment associated with restless legs syndrome. 2 However, when we compared the symptom profile of major depressive disorder between participants with and without restless legs syndrome, we found no differences between their endorsements of other depressive symptom items (i.e., depressed mood, appetite change, guilt, anhedonia, and suicidal thoughts) less related to sleep impairment. Another explanation for co-occurrence of restless legs syndrome and DSM-IV major depressive disorder is antidepresant use. It is commonly believed that antidepressant use is associated with restless legs syndrome, and many anecdotal reports of TCAs and SSRIs causing or exacerbating restless legs syndrome symptoms exist. 2 However, a recent retrospective chart review study of 200 insomnia patients reported a lack of association between restless legs syndrome and antidepressant use. 7 Similarly, we found no association between antidepressant use and restless legs syndrome symptoms. A systematic, prospective study on a clinical restless legs syndrome sample is further needed to examine this hypothesized association between antidepressant use and restless legs syndrome symptoms. Alternatively, an underlying shared pathophysiological mechanism might be responsible for the comorbidity between restless legs syndrome and major depressive disorder. The role of dopaminergic pathology in restless legs syndrome has been established through multiple studies, 8 and a role for dopamine reward circuits in depression has been proposed. 9 Bupropion, which has proven efficacy in the treatment of depression, acts, at least in part, via promoting dopaminergic function. 10 Several clinical trials reported a potential role for dopamine agonists, the first line agent for treatment of restless legs syndrome, in the treatment of treatmentresistant depression or bipolar depression. 11 The high prevalence of panic disorder among subjects with restless legs syndrome is even more intriguing as little symptomatic overlap exists between the two conditions. Similarly, a high rate of comorbidity with panic disorder and major depressive disorder is observed among patients with Parkinson s disease, a neurodegenerative disorder primarily involving central dopaminergic tracts. 12 Psychiatric comorbidities of Parkinson s disease have been attributed to direct dopaminergic deficit or interactions between dopaminergic deficits, as well as the variable deficits in norepinephrine and serotonin that are known to occur in Parkinson s disease. 13 Few studies have examined the role of noradrenergic or serotonergic neurotransmission in the pathophysiology of restless legs syndrome. There are several limitations to this study. Since the RLS Questionnaire was administered only during Wave IV, we cannot examine the direction of causality. Also, the diagnosis of restless legs syndrome in this study was based on the participants responses to the seven-item RLS Questionnaire, which may not have been specific enough to distinguish restless legs syndrome from other mimics (e.g., neuroleptic-induced akathisia). In general, however, restless legs syndrome occurs without exposure to dopamine-blocking medication; only one out of 42 participants with restless legs syndrome in our study was on a dopamine-blocking agent (quetiapine). Furthermore, the small number of participants with restless legs syndrome and psychiatric disorders does not allow us to examine the association between restless legs syndrome and less common psychiatric disorders such as bipolar disorder and schizophrenia. Future investigations should examine the symptomatic and pathophys J Neuropsychiatry Clin Neurosci 20:1, Winter 2008
5 LEE et al. iological overlap between restless legs syndrome and major depressive disorder or panic disorder that frequently co-occur in the community. This research was supported by NIMH Grant MH47447 and MH and National Institute of Aging Grant AG References 1. Allen RP, Picchietti D, Hening WA, et al: Restless legs syndrome: diagnostic criteria, special considerations, and epidemiology: a report from the restless legs syndrome diagnosis and epidemiology workshop at the National Institutes of Health. Sleep Med 2003; 4: Picchietti D, Winkelman SW: Restless legs syndrome, periodic limb movements in sleep, and depression. Sleep 2005; 28: Robins LN, Helzer J, Croughan J, et al: The NIMH Diagnostic Interview Schedule: its history, characteristics and validity. Arch Gen Psychiatry 1981; 38: Regier DA, Myers JK, Kramer M, et al: The NIMH Epidemiologic Catchment Area Program: historical context, major objectives, and study population characteristics. Arch Gen Psychiatry 1984; 41: Berger KJ, Luedemann J, Trenkwalder C, et al: Sex and restless legs syndrome in the general population. Arch Intern Med 2004; 164: Winkelmann J, Prager M, Lieb R, et al: Anxietas tibiarum: Depression and anxiety disorders in patients with restless legs syndrome. J Neurol 2005; 252: Brown LK, Dedrick DL, Doggett JW, et al: Antidepressant medication use and restless legs syndrome in patients presenting with insomnia. Sleep Med 2005; 6: Allen RP: Dopamine and iron in the pathophysiology of restless legs syndrome. Sleep Med 2004; 5: Nestler EJ, Carlezon WA Jr: The mesolimbic dopamine reward circuit in depression. Biol Psychiatry 2006; 59: Feigher JP, Meredith CH, Stern WC, et al: A double-blind study of bupropion and placebo in depression. Am J Psychiatry 1984; 141: Goldberg JF, Burdick KE, Endick CJ: Preliminary randomized, double-blind, placebo-controlled trial of pramipexole added to mood stabilizers for treatment-resistant bipolar depression. Am J Psychiatry 2004; 161: Menza MA, Robertson-Hoffman DE, Bonapace AS: Parkinson s disease and anxiety: comorbidity with depression. Biol Psychiatry 1993; 34: Cummings JL: Depression and Parkinson s disease: a review. Am J Psychiatry 1992; 149: J Neuropsychiatry Clin Neurosci 20:1, Winter
Depression and RLS. John W. Winkelman MD, PhD Departments of Psychiatry and Neurology Massachusetts General Hospital
Depression and RLS John W. Winkelman MD, PhD Departments of Psychiatry and Neurology Massachusetts General Hospital Associate Professor of Psychiatry Harvard Medical School A 42 year old man has a three
More informationTransitions in Depressive Symptoms After 10 Years of Follow-up Using PROC LTA
PharmaSUG 2015 Paper QT25 Transitions in Depressive Symptoms After 10 Years of Follow-up Using PROC LTA Seungyoung Hwang, Johns Hopkins University Bloomberg School of Public Health ABSTRACT PROC LTA is
More informationMeasurement of Psychopathology in Populations. William W. Eaton, PhD Johns Hopkins University
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike License. Your use of this material constitutes acceptance of that license and the conditions of use of materials on this
More informationAddressing Psychiatric Issues Prior to HCV Treatment. Glenn J. Treisman, MD, PhD The Johns Hopkins University School of Medicine Baltimore, Maryland
Addressing Psychiatric Issues Prior to HCV Treatment Glenn J. Treisman, MD, PhD The Johns Hopkins University School of Medicine Baltimore, Maryland Disclosure Information Dr Treisman has not relevant financial
More informationPrevalence of anxiety and depressive symptoms in men with erectile dysfunction
Prevalence of anxiety and depressive symptoms in men with erectile dysfunction K Pankhurst, MB ChB G Joubert, BA, MSc P J Pretorius, MB ChB, MMed (Psych) Departments of Psychiatry and Biostatistics, University
More informationGuilt Suicidality. Depression Co-Occurs with Medical Illness The rate of major depression among those with medical illness is significant.
1-800-PSYCH If you are obsessive-compulsive, dial 1 repeatedly If you are paranoid-delusional, dial 2 and wait, your call is being traced If you are schizophrenic, a little voice will tell you what number
More informationA Basic Approach to Mood and Anxiety Disorders in the Elderly
A Basic Approach to Mood and Anxiety Disorders in the Elderly November 1 2013 Sarah Colman MD FRCPC Clinical Fellow, Geriatric Psychiatry Mount Sinai Hospital, University of Toronto Disclosure No conflict
More informationSome newer, investigational approaches to treating refractory major depression are being used.
CREATED EXCLUSIVELY FOR FINANCIAL PROFESSIONALS Rx FOR SUCCESS Depression and Anxiety Disorders Mood and anxiety disorders are common, and the mortality risk is due primarily to suicide, cardiovascular
More informationLong-Term Treatment of Restless Legs Syndrome (RLS): An Approach to Management of Worsening Symptoms, Loss of Efficacy, and Augmentation
CNS Drugs (2015) 29:351 357 DOI 10.1007/s40263-015-0250-2 CURRENT OPINION Long-Term Treatment of Restless Legs Syndrome (RLS): An Approach to Management of Worsening Symptoms, Loss of Efficacy, and Augmentation
More informationClinical Significance of Anxiety in Depressed Patients Selecting an Antidepressant
The Clinical Significance of Anxiety Disorders and the DSM-5 Anxious Distress Specifier in Depressed Patients Clinical Significance of Anxiety in Depressed Patients Selecting an Antidepressant Rhode Island
More informationChallenges in identifying and treating bipolar depression: a guide
Challenges in identifying and treating bipolar depression: a guide Dr. Paul Stokes Clinical Senior Lecturer, Centre for Affective Disorders, Department of Psychological Medicine Overview Challenges in
More informationMigraine, major depression and panic disorder: a prospective epidemiologic study of young adults
Migraine, major depression and panic disorder: a prospective epidemiologic study of young adults Naomi Breslau. Glenn C Davis Department of Psychiatry, Henry Ford Hospital Detroit, MI Ce1!.halal~ Breslau
More informationPediatric Psychopharmacology
Pediatric Psychopharmacology General issues to consider. Pharmacokinetic differences Availability of Clinical Data Psychiatric Disorders can be common in childhood. Early intervention may prevent disorders
More informationPD ExpertBriefing: Impulsive and Compulsive Behaviors in Parkinson s Disease
PD ExpertBriefing: Impulsive and Compulsive Behaviors in Parkinson s Disease Presented By: Daniel Weintraub, M.D. Associate Professor of Psychiatry, University of Pennsylvania; Parkinson s Disease and
More informationDepression, Antidepressants, and Bone Mineral Density in a Population-Based Cohort
Journal of Gerontology: MEDICAL SCIENCES 2008, Vol. 63A, No. 12, 1410 1415 Copyright 2008 by The Gerontological Society of America Depression, Antidepressants, and Bone Mineral Density in a Population-Based
More informationINTRODUCTION TO MENTAL HEALTH. PH150 Fall 2013 Carol S. Aneshensel, Ph.D.
INTRODUCTION TO MENTAL HEALTH PH150 Fall 2013 Carol S. Aneshensel, Ph.D. Topics Subjective Experience: From the perspective of mentally ill persons Context Public attitudes toward the mentally ill Definition
More informationWhen is a Psychological Disorder a Disability? Dr. Leigh Ann Ford, PhD, HSP Licensed Psychologist ABVE 2017 Annual Conference. Goals for presentation
When is a Psychological Disorder a Disability? Dr. Leigh Ann Ford, PhD, HSP Licensed Psychologist ABVE 2017 Annual Conference Goals for presentation *To review DSM-V criteria for some of the most frequently
More informationThe Prevention & Treatment of Augmentation
The Prevention & Treatment of Augmentation MARK J BUCHFUHRER, MD S T A N F O R D U N I VERSITY S L E E P M E D I C IN E C E N T ER, R E D W O O D C I T Y, C A P R I VATE P R ACTICE, D O W N E Y, C A 2017
More informationMental Health Issues and Treatment
Mental Health Issues and Treatment Mental health in older age Depression Causes of depression Effects of depression Suicide Newsom, Winter 2017, Psy 462/562 Psychology of Adult Development and Aging 1
More informationSLEEP DISTURBANCE AND ALCOHOL PROBLEMS sleep disturbances may be intermittent and the practice of self-medication with alcohol inconsistent over time,
Article Sleep Disturbance and Risk for Alcohol-Related Problems Rosa M. Crum, M.D., M.H.S. Carla L. Storr, Sc.D. Ya-Fen Chan, M.S.N. Daniel E. Ford, M.D., M.P.H. Objective: Using prospective data, the
More informationIndex. Note: Page numbers of article titles are in boldface type. A ADHD. See Attention-deficit/hyperactivity disorder (ADHD) b-adrenergic blockers
Note: Page numbers of article titles are in boldface type. A ADHD. See Attention-deficit/hyperactivity disorder (ADHD) a-adrenergic blockers for PTSD, 798 b-adrenergic blockers for PTSD, 798 Adrenergic
More informationMental Health Rotation Educational Goals & Objectives
Mental Health Rotation Educational Goals & Objectives Mental illness is prevalent in the general population and is commonly seen and treated in the office of the primary care provider. Educational experiences
More informationBasics of Restless Legs Syndrome (Willis-Ekbom Disease)
Basics of Restless Legs Syndrome (Willis-Ekbom Disease) Michael H. Silber, M.B.Ch.B. Professor of Neurology Mayo Clinic College of Medicine Objectives Understand how RLS is diagnosed Understand what we
More informationDepression major depressive disorder. Some terms: Major Depressive Disorder: Major Depressive Disorder:
Depression major depressive disorder Oldest recognized disorder: melancholia It is a positive and active anguish, a sort of psychical neuralgia wholly unknown to normal life. - William James "I am now
More informationDEPRESSION AND ANXIETY STATUS IN KANSAS
DEPRESSION AND ANXIETY STATUS IN KANSAS 2011 Behavioral Risk Factor Surveillance System This report was prepared by the Bureau of Health Promotion, Kansas Department of Health and Environment February
More informationORIGINAL ARTICLE. Introduction
ORIGINAL ARTICLE (2009) 14, 1051 1066 & 2009 Nature Publishing Group All rights reserved 1359-4184/09 $32.00 www.nature.com/mp Sociodemographic and psychopathologic predictors of first incidence of DSM-IV
More informationDeposited on: 15 May 2008 Glasgow eprints Service
Gilchrist, G. and Gruer, L. and Atkinson, J. (2005) Comparison of drug use and psychiatric morbidity between prostitute and non-prostitute female drug users in Glasgow, Scotland. Addictive Behaviors 30(5):pp.
More information6/22/2012. Co-morbidity - when two or more conditions occur together. The two conditions may or may not be causally related.
Autism Spectrum Disorders and Co-existing Mental Health Issues By Dr. Karen Berkman Objective To present an overview of common psychiatric conditions that occur in persons with autism spectrum disorders
More informationReducing the Anxiety of Pediatric Anxiety Part 2: Treatment
Reducing the Anxiety of Pediatric Anxiety Part 2: Treatment Lisa Lloyd Giles, MD Medical Director, Behavioral Consultation, Crisis, and Community Services Primary Children s Hospital Associate Professor,
More informationPSYCHIATRIC CO-MORBIDITY STEVE SUGDEN MD MPH
PSYCHIATRIC CO-MORBIDITY STEVE SUGDEN MD MPH OVERVIEW: PSYCHIATRIC DISORDERS Mood Disorders Anxiety Disorders Psychotic Disorders Personality Disorders PTSD Eating Disorders EXAMPLE What is the diagnosis?
More informationTransitions in Depressive Symptoms After 10 Years of Follow-up Using PROC LTA in SAS and Mplus
Paper PH-01-2015 Transitions in Depressive Symptoms After 10 Years of Follow-up Using PROC LTA in SAS and Mplus Seungyoung Hwang, Johns Hopkins University Bloomberg School of Public Health ABSTRACT PROC
More informationHDSA welcomes you to Caregiver s Corner. Funded by an educational grant from
HDSA welcomes you to Caregiver s Corner Funded by an educational grant from Caregiver s Corner Webinar, DATE Managing Psychiatric Symptoms Peg Nopoulos, M.D. Professor of Psychiatry, Neurology, and Pediatrics
More informationFrailty and Depression in Late Life
1 Frailty and Depression in Late Life Patrick J. Brown, PH.D Assistant Professor of Clinical Psychology in Psychiatry College of Physicians and Surgeons, Columbia University New York State Psychiatric
More information9/24/2012. Amer M Burhan, MBChB, FRCP(C)
Depression and Dementia Amer M Burhan MBChB, FRCPC Head of CAMH Memory Clinic, Toronto Geriatric Neuropsychiatrist Assistant Prof Psychiatry at U of T Objectives Discuss the prevalence and impact of depression
More informationPsychiatry in Primary Care: What is the Role of Pharmacist?
Psychiatry in Primary Care: What is the Role of Pharmacist? Benjamin Chavez, PharmD, BCPP, BCACP Clinical Associate Professor Director of Behavioral Health Pharmacy Services January 12, 2019 Disclosure
More informationAre Anti depressants Effective in the Treatment of Depressed Patients Who Do Not Seek Psychotherapy?
Philadelphia College of Osteopathic Medicine DigitalCommons@PCOM PCOM Physician Assistant Studies Student Scholarship Student Dissertations, Theses and Papers 2012 Are Anti depressants Effective in the
More informationConsultant Pharmacist Approach to Major Depressive Disorder
Consultant Pharmacist Approach to Major Depressive Disorder ALAN OBRINGER RPH, CPH, CGP PRESIDENT/OWNER GUARDIAN PHARMACY OF ORLANDO Objectives What is Depression? Discuss the epidemiology of depression
More informationConsultant Pharmacist Approach to Major Depressive Disorder ALAN OBRINGER RPH, CPH, CGP PRESIDENT/OWNER GUARDIAN PHARMACY OF ORLANDO
Consultant Pharmacist Approach to Major Depressive Disorder ALAN OBRINGER RPH, CPH, CGP PRESIDENT/OWNER GUARDIAN PHARMACY OF ORLANDO Objectives What is Depression? Discuss the epidemiology of depression
More informationUPDATE April 5, 2006 BRIEFING DOCUMENT. Paroxetine Adult Suicidality Analysis: Major Depressive Disorder and Non- Major Depressive Disorder
UPDATE April 5, 2006 BRIEFING DOCUMENT Paroxetine Adult Suicidality Analysis: Major Depressive Disorder and Non- Major Depressive Disorder 1. Introduction Selective serotonin reuptake inhibitors (SSRIs)
More informationThe cientificworldjournal. Hiroaki Hori and Hiroshi Kunugi. 1. Introduction
The Scientific World Journal Volume 2012, Article ID 372474, 8 pages doi:10.1100/2012/372474 The cientificworldjournal Clinical Study The Efficacy of Pramipexole, a Dopamine Receptor Agonist, as an Adjunctive
More informationAmy Edmondson Mulroy, MD
Curriculum Vitae Amy Edmondson Mulroy, MD 7940 Floyd Curl Drive, Suite 700 7940 Floyd Curl Drive, Suite 1020 San Antonio, Texas 78229 San Antonio, Texas 78229 EDUCATION 1997 General Adult Psychiatry Internship
More informationANXIETY DISORDERS AND RISK FOR SUICIDE ATTEMPTS: FINDINGS FROM THE BALTIMORE EPIDEMIOLOGIC CATCHMENT AREA FOLLOW-UP STUDY
DEPRESSION AND ANXIETY 0:1 5 (2007) Research Article ANXIETY DISORDERS AND RISK FOR SUICIDE ATTEMPTS: FINDINGS FROM THE BALTIMORE EPIDEMIOLOGIC CATCHMENT AREA FOLLOW-UP STUDY James M. Bolton, M.D., 1 Brian
More informationA randomized controlled clinical trial of Citalopram versus Fluoxetine in children and adolescents with obsessive-compulsive disorder (OCD)
Eur Child Adolesc Psychiatry (2009) 18:131 135 DOI 10.1007/s00787-007-0634-z ORIGINAL CONTRIBUTION Javad Alaghband-Rad Mitra Hakimshooshtary A randomized controlled clinical trial of Citalopram versus
More informationORIGINAL INVESTIGATION. Epidemiology of Restless Legs Symptoms in Adults
ORIGINAL INVESTIGATION Epidemiology of Restless Legs Symptoms in Adults Barbara Phillips, MD, MSPH, FCCP; Terry Young, PhD; Laurel Finn, MS; Karen Asher, BA; Wayne A. Hening, MD, PhD; Cheryl Purvis, PhD
More informationPost-Stroke Depression Primary Care Stroke Update: What s New in Best Practice Prevention & Care
Post-Stroke Depression Primary Care Stroke Update: What s New in Best Practice Prevention & Care Maria Hussain MD FRCPC Dallas Seitz MD PhD(c) FRCPC Division of Geriatric Psychiatry, Queen s University
More informationFluoxetine, a specific serotonin uptake inhibitor, is approved for use as an antidepressant in adults and
JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY Volume, Number, 99/99 Mary Ann Liebert, Inc., Publishers Behavioral Side Effects of Fluoxetine in Children and Adolescents MARK A. RIDDLE, M.D., ROBERT
More informationBipolar Disorder 4/6/2014. Bipolar Disorder. Symptoms of Depression. Mania. Depression
Bipolar Disorder J. H. Atkinson, M.D. Professor of Psychiatry HIV Neurobehavioral Research Programs University of California, San Diego KETHEA, Athens Slides courtesy of John Kelsoe, M.D. Bipolar Disorder
More informationPractice Matters: Screening and Referring Congregants with Major Depression
International Journal of Faith Community Nursing Volume 1 Issue 3 Article 6 October 2015 Practice Matters: Screening and Referring Congregants with Major Depression Kim Link Western Kentucky University
More informationResearch Article Restless Leg Syndrome in Diabetics Compared with Normal Controls
Sleep Disorders, Article ID 871751, 4 pages http://dx.doi.org/10.1155/2014/871751 Research Article Restless Leg Syndrome in Diabetics Compared with Normal Controls Mehdi Zobeiri 1 and Azita Shokoohi 2
More informationDepression and Anxiety. What is Depression? What is Depression? By Christopher Okiishi, MD Spring Not just being sad A syndrome of symptoms
Depression and Anxiety By Christopher Okiishi, MD Spring 2016 What is Depression? Not just being sad A syndrome of symptoms Depressed mood Sleep disturbance Decreased interest in usual activities (anhedonia)
More informationAging with Bipolar Disorder. Neha Jain, MD, FAPA Assistant Professor of Psychiatry, UConn Health
Aging with Bipolar Disorder Neha Jain, MD, FAPA Assistant Professor of Psychiatry, UConn Health Objectives Define bipolar disorder in the elderly Review comorbidities How does it differ from bipolar in
More informationA Clinical Translation of the Research Article Titled Antisocial Behavioral Syndromes and. Additional Psychiatric Comorbidity in Posttraumatic Stress
1 A Clinical Translation of the Research Article Titled Antisocial Behavioral Syndromes and Additional Psychiatric Comorbidity in Posttraumatic Stress Disorder among US Adults: Results from Wave 2 of the
More informationMENTAL health disparities across socioeconomic status
Journals of Gerontology: SERIES B 2005, Vol. 60B (Special Issue II): 93 98 Copyright 2005 by The Gerontological Society of America Topic 4. Economic Status and Health Inequalities Mental Health Disparities
More informationMental Health Disorders Associated with RLS
Mental Health Disorders Associated with RLS 2 Mark A. Oldham and Hochang B. Lee In the middle of the nineteenth century, Wittmaack reported on the co-occurrence of restless legs and psychiatric symptoms
More informationAnnouncements. Grade Query Tool+ PsychPortal. Final Exam Wed May 9, 1-3 pm
Grade Query Tool+ Announcements This tool is the definitive source for your final grade! Now includes Grade Estimator Tool PsychPortal Technical glitches in Learning Curves for Chapters 5, 14, and 15 are
More informationMental illness A Broad Overview. Dr H Pathmanandam March 2017
Mental illness A Broad Overview Dr H Pathmanandam March 2017 Introduction Mental disorders are common in primary and secondary care Many are not recognised and not treated Some receive unnecessary or inappropriate
More informationManual of Clinical Psychopharmacology
Manual of Clinical Psychopharmacology Fourth Edition Alan F. Schatzberg, M.D. Kenneth T. Norris, Jr., Professor and Chairman, Department of Psychiatry and Behavioral Sciences, Stanford University School
More informationIndex. Note: Page numbers of article titles are in boldface type.
Index Note: Page numbers of article titles are in boldface type. A Abuse alcohol, aggression and, 52 53 substance, aggression and, 52 54 ACE. See Aid to Capacity Evaluation (ACE). AEDs. See Antiepileptic
More informationStudy No.: Title: Rationale: Phase: Study Period: Study Design: Centers: Indication: Treatment: Objectives: Primary Outcome/Efficacy Variable:
Study No.: 29060/717 Title: A Double-Blind, Placebo-Controlled, 3-Arm, Fixed-Dose Study of CR Intermittent Dosing (12.5 mg and 25 mg) for Premenstrual Dysphoric Disorder Rationale: In most trials investigating
More informationDepression Assessment and Management. John Kern MD Clinical Professor University of Washington
Depression Assessment and Management John Kern MD Clinical Professor University of Washington Handouts Antidepressant Treatment Flowchart Managing antidepressant nonresponse handouts 2 Diagnosis PHQ-9
More informationWellbutrin/Wellbutrin-SR/ Wellbutrin-XL (bupropion)
Wellbutrin/Wellbutrin-SR/ Wellbutrin-XL (bupropion) Generic name: Bupropion Available strengths: 75 mg, 100 mg immediate-release tablets; 100 mg, 150 mg, 200 mg sustained-release tablets (Wellbutrin-SR);
More informationAre All Older Adults Depressed? Common Mental Health Disorders in Older Adults
Are All Older Adults Depressed? Common Mental Health Disorders in Older Adults Cherie Simpson, PhD, APRN, CNS-BC Myth vs Fact All old people get depressed. Depression in late life is more enduring and
More informationDepression in the Medically Ill
Mayo School of Continuous Professional Development Psychiatry in Medical Settings February 9 th, 2017 Depression in the Medically Ill David Katzelnick, M.D. Professor of Psychiatry, Mayo Clinic College
More informationEpidemiology Old Age
Epidemiology Old Age Chris Gale Otago Regional Psychiatry Training Programme March 2011 Criteria Validity of a Psychiatric Diagnosis (see Sachdev, 1999). (1) shared genetic risk factors ; (2) familiality
More informationBehavioral Aspects of Parkinson s Disease
Behavioral Aspects of Parkinson s Disease Joseph H. Friedman, MD Director, Movement Disorders Program Butler Hospital Dept of Neurology Alpert Medical School of Brown University 1 Disclosures Drugs will
More informationIntroduction, Nosology, and History. William W. Eaton, PhD Johns Hopkins University
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike License. Your use of this material constitutes acceptance of that license and the conditions of use of materials on this
More informationSuitable dose and duration of fluvoxamine administration to treat depression
PCN Psychiatric and Clinical Neurosciences 1323-13162003 Blackwell Science Pty Ltd 572April 2003 1098 Dose and duration of fluvoxamine S. Morishita and S. Arita 10.1046/j.1323-1316.2002.01098.x Original
More informationAugmentation and Combination Strategies in Antidepressants treatment of Depression
Augmentation and Combination Strategies in Antidepressants treatment of Depression Byung-Joo Ham, M.D. Department of Psychiatry Korea University College of Medicine Background The response rates reported
More informationThe STAR-MH screening tool for identifying mental disorders in asylum seekers and new refugees
March 28-31, 2017 Sydneyo. The STAR-MH screening tool for identifying mental disorders in asylum seekers and new refugees Dr Debbie Hocking 1,2,3, Prof Suresh Sundram 2,3,4, Dr Sam Mancuso 4 1. Cabrini
More informationMood Disorders and Addictions: A shared biology?
Mood Disorders and Addictions: A shared biology? Dr. Paul Stokes Clinical Senior Lecturer, Centre for Affective Disorders, Department of Psychological Medicine Disclosures No relevant disclosures: No paid
More informationRestless Leg Syndrome in Patients Referred for Obstructive Sleep Apnea
ORIGINAL ARTICLE Restless Leg Syndrome in Patients Referred for Obstructive Sleep Apnea Department of Pulmonary Medicine ESI-PGIMSR Basaidarapur, New Delhi-110015 DOI No:10.5958/0974-0155.2016.00016.4
More informationDifferentiating Unipolar vs Bipolar Depression in Children
Differentiating Unipolar vs Bipolar Depression in Children Mai Uchida, M.D. Director, Center for Early Identification and Prevention of Pediatric Depression Massachusetts General Hospital Assistant Professor
More informationDepression in Late Life
Depression in Late Life Robert Madan MD FRCPC Geriatric Psychiatrist Key Learnings Robert Madan MD FRCPC Key Learnings By the end of the session, participants will be able to List the symptoms of depression
More informationAN OVERVIEW OF ANXIETY
AN OVERVIEW OF ANXIETY Fear and anxiety are a normal part of life. Normal anxiety keeps us alert. Intervention is required when fear and anxiety becomes overwhelming intruding on a persons quality of life.
More informationExplain to patients and families the meaning and ramifications of FDA warnings regarding antidepressants. Appropriately monitor patients on
Antidepressants in Children and Adolescents: The Good, The Bad & The Ugly Raymond C. Love, Pharm.D., BCPP, FASHP Associate Dean and Professor, Pharmacy Practice & Science University of Maryland, School
More informationPharmacists in Medication Adherence in Psychiatric Patients
Pharmacists in Medication Adherence in Psychiatric Patients Mamta Parikh, PharmD, BCPS, BCPP Assistant Professor, Clinical and Administrative Sciences Notre Dame of Maryland University School of Pharmacy
More informationPsychosis, Mood, and Personality: A Clinical Perspective
Psychosis, Mood, and Personality: A Clinical Perspective John R. Chamberlain, M.D. Assistant Director, Psychiatry and the Law Program Assistant Clinical Professor University of California San Francisco
More informationCover Page. The handle holds various files of this Leiden University dissertation
Cover Page The handle http://hdl.handle.net/1887/25851 holds various files of this Leiden University dissertation Author: Molendijk, M.L. Title: The role of BDNF in depression : will the neurotrophin hypothesis
More informationComorbidity of Depression and Other Diseases
Comorbidity of Depression and Other Diseases JMAJ 44(5): 225 229, 2001 Masaru MIMURA Associate Professor, Department of Psychiatry, Showa University, School of Medicine Abstract: This paper outlines the
More informationDEPRESSION AFTER STROKE
DEPRESSION AFTER STROKE Research study results and practical suggestions Julie Kidd 1 November 2018 Outline Definition Diagnosis Associations Prevention Treatment Outcomes From a person with stroke Emphasises
More informationAntidepressant Use and Depressive Symptoms in Intensive Care Unit Survivors
Antidepressant Use in ICU Survivors 1 Antidepressant Use and Depressive Symptoms in Intensive Care Unit Survivors Sophia Wang, MD, Chris Mosher, MD, Sujuan Gao, PhD, Kayla Kirk, MA, Sue Lasiter, PhD, RN,
More informationAMPS : A Quick, Effective Approach To The Primary Care Psychiatric Interview
AMPS : A Quick, Effective Approach To The Primary Care Psychiatric Interview February 7, 2012 Robert McCarron, D.O. Assosicate Clinical Professor Internal Medicine / Psychiatry / Pain Medicine UC Davis,
More informationMOOD (AFFECTIVE) DISORDERS and ANXIETY DISORDERS
MOOD (AFFECTIVE) DISORDERS and ANXIETY DISORDERS Shelley Klipp AS91 Spring 2010 TIP 42 Pages 226-231 and 369-379 DSM IV-TR APA 2000 Co-Occurring Substance Abuse and Mental Disorders by John Smith Types
More informationDEMENTIA and BPSD in PARKINSON'S DISEASE. DR. T. JOHNSON. NOVEMBER 2017.
DEMENTIA and BPSD in PARKINSON'S DISEASE. DR. T. JOHNSON. NOVEMBER 2017. Introduction. Parkinson's disease (PD) has been considered largely as a motor disorder. It has been increasingly recognized that
More informationEPIDEMIOLOGY : GENERAL CONCEPTS, METHODS AND MAJOR STUDIES
UNIT 1 EPIDEMIOLOGY : GENERAL CONCEPTS, METHODS AND MAJOR STUDIES Structure 1.1 Introduction 1.2 Objectives 1.3 Concept of Epidemiology 1.4 Epidemiological Methods 1.4.1 Measures of Disease Frequency 1.4.2
More informationΝευροφυσιολογία και Αισθήσεις
Biomedical Imaging & Applied Optics University of Cyprus Νευροφυσιολογία και Αισθήσεις Διάλεξη 19 Ψυχασθένειες (Mental Illness) Introduction Neurology Branch of medicine concerned with the diagnosis and
More informationPrepared by: Elizabeth Vicens-Fernandez, LMHC, Ph.D.
Prepared by: Elizabeth Vicens-Fernandez, LMHC, Ph.D. Sources: National Institute of Mental Health (NIMH), the National Alliance on Mental Illness (NAMI), and from the American Psychological Association
More informationStudy Guide Unit 3 Psych 2022, Fall 2003
Psychological Disorders: General Study Guide Unit 3 Psych 2022, Fall 2003 1. What are psychological disorders? 2. What was the main treatment for some psychological disorders prior to the 1950 s? 3. What
More informationDepression Management
Depression Management Ulka Agarwal, M.D. Adjunct Psychiatrist Pine Rest Christian Mental Health Disclosures The presenter and all planners of this education activity do not have a financial/arrangement
More informationSupplementary Online Content
Supplementary Online Content Daly EJ, Singh JB, Fedgchin M, et al. Efficacy and safety of intranasal esketamine adjunctive to oral antidepressant therapy in treatment-resistant depression: a randomized
More information5 COMMON QUESTIONS WHEN TREATING DEPRESSION
5 COMMON QUESTIONS WHEN TREATING DEPRESSION Do Antidepressants Increase the Possibility of Suicide? Will I Accidentally Induce Mania if I Prescribe an SSRI? Are Depression Medications Safe and Effective
More informationThis was a randomized, double-blind, placebo-controlled, fixed-dose, parallel-group study.
The study listed may include approved and non-approved uses, formulations or treatment regimens. The results reported in any single study may not reflect the overall results obtained on studies of a product.
More informationSession 3: Help Me, Doc - I ve Got High Anxiety! Learning Objectives
Session 3: Help Me, Doc - I ve Got High Anxiety! Learning Objectives 1. Recognize the distinguishing features of common anxiety disorders seen in primary care. 2. Use screening measures for diagnosis of
More informationEstimates of Prevalence of Mental Health Problems by Locality
Estimates of Prevalence of Mental Health Problems by Locality How can the level of mental illness now and in the future be estimated in order to plan services? It is possible to make estimates by locality
More informationDiabetes and Depression. Roshini Pinto-Powell, MD Stephen Noyes, LICSW, LADC William Gunn, PhD Beverly Bean, RN, C
Diabetes and Depression Roshini Pinto-Powell, MD Stephen Noyes, LICSW, LADC William Gunn, PhD Beverly Bean, RN, C 2008 Learning Objectives State the risk factors for depression Identify the vulnerability
More informationObjectives. DSM-V Changes: Elimination of Multiaxial Diagnostic System
Conflicts of Interest I have no conflicts to disclose. 2014 Updates to the Updates in Pharmacotherapy Webinar Psychiatry Updates for Pharmacotherapy Specialists Jacintha S. Cauffield, Pharm.D., BCPS Associate
More informationDEPRESSION. Dr. Jonathan Haverkampf, M.D.
Dr., M.D. Depression is one of the most common medical conditions, which can interfere with a person s quality of life, relationships and ability to work significantly. Fortunately, there are a number
More informationChristopher J. Earley, MB, BCh, PhD Professor Department of Neurology Johns Hopkins School of Medicine
Christopher J. Earley, MB, BCh, PhD Professor Department of Neurology Johns Hopkins School of Medicine 1. Medication working well but do you still need it? 2. Medication working well but do you really
More informationAffective or Mood Disorders. Dr. Alia Shatanawi March 12, 2018
Affective or Mood Disorders Dr. Alia Shatanawi March 12, 2018 Affective or Mood Disorders Reactive Depression. Secondary: Medical Neurological Drugs Major (Endogenous) Depression = Unipolar: Depressed
More informationComorbidities of Migraine
Comorbidities of Migraine Richard B. Lipton, MD Edwin S Lowe Professor and Vice Chair of Neurology Director, Montefiore Headache Center Albert Einstein College of Medicine Overview What is comorbidity?
More information